We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$32.6B
AUM Growth
+$1.87B
Cap. Flow
+$3.25B
Cap. Flow %
9.96%
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$197M
2
TDG icon
TransDigm Group
TDG
+$181M
3
AAPL icon
Apple
AAPL
+$148M
4
ORCL icon
Oracle
ORCL
+$133M
5
ACC
American Campus Communities, Inc.
ACC
+$128M

Sector Composition

Rank Sector Weight
1 Industrials 11.6%
2 Technology 10.81%
3 Financials 10.76%
4 Consumer Discretionary 10.14%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
2851
Crown Castle
CCI
$32.5B
-2,839
Closed -$478K
CCK icon
2852
Crown Holdings
CCK
$13B
-246,937
Closed -$22.8M
CDLX icon
2853
Cardlytics
CDLX
$25.3M
-1,305
Closed -$291K
CEG icon
2854
Constellation Energy
CEG
$97.2B
-10,974
Closed -$628K
CENN icon
2855
Cenntro
CENN
$9.85M
-145
Closed -$131K
CF icon
2856
PUT
CF Industries
CF
$19.5B
-5,000
Closed -$429K
CGEN icon
2857
CALL
Compugen
CGEN
$243M
-100,000
Closed -$185K
CHGG icon
2858
CALL
Chegg
CHGG
$89.5M
-250,000
Closed -$4.7M
CHH icon
2859
Choice Hotels
CHH
$4.96B
-353,989
Closed -$39.5M
CHRS icon
2860
CALL
Coherus Oncology
CHRS
$215M
-410,000
Closed -$2.97M
CIA icon
2861
Citizens
CIA
$196M
-16,389
Closed -$69K
CINF icon
2862
Cincinnati Financial
CINF
$26.2B
-118,762
Closed -$14.1M
CLNE icon
2863
Clean Energy Fuels
CLNE
$355M
-152,020
Closed -$681K
CLVT icon
2864
Clarivate
CLVT
$1.36B
-126,862
Closed -$1.76M
CLX icon
2865
Clorox
CLX
$13.1B
-53,400
Closed -$7.71M
CM icon
2866
Canadian Imperial Bank of Commerce
CM
$105B
-7,014
Closed -$340K
CMA
2867
CALL
DELISTED
Comerica
CMA
-77,500
Closed -$5.69M
CMCO icon
2868
Columbus McKinnon
CMCO
$518M
-13,825
Closed -$392K
CMS icon
2869
CMS Energy
CMS
$21.5B
-387,589
Closed -$26.2M
CNMD icon
2870
CONMED
CNMD
$1.55B
-216,495
Closed -$20.7M
COO icon
2871
Cooper Companies
COO
$14.8B
-17,836
Closed -$1.4M
COR icon
2872
PUT
Cencora
COR
$61.5B
-10,000
Closed -$1.42M
COTY icon
2873
CALL
Coty
COTY
$2.47B
-25,000
Closed -$200K
COST icon
2874
PUT
Costco
COST
$429B
-5,000
Closed -$2.4M
CPNG icon
2875
Coupang
CPNG
$29.5B
-1,301,215
Closed -$16.6M

Similar funds

Dmitry Balyasny's Q3 2022 Portfolio in Review

As of Q3 2022, Dmitry Balyasny held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Dmitry Balyasny deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.

  • Dmitry Balyasny's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
  • Dmitry Balyasny's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
  • Dmitry Balyasny fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
  • Dmitry Balyasny's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
  • Dmitry Balyasny opened 825 new positions and closed 693 in Q3 2022.
  • Dmitry Balyasny's portfolio value rose 6.1% quarter-over-quarter to $32.6B.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.